Results 241 to 250 of about 196,164 (338)
Causal relationship between immune cells and idiopathic thrombocytopenic purpura: A bidirectional Mendelian randomization study
Rheumatology &Autoimmunity, EarlyView.Heyi Zhang, Luyao Song, Ying Mao, Zerui Liu, Zhexi He, Mengxia Liu, Jingfang Zhang, Rui Zhao, Jing Luo, Shengxiao Zhang +9 morewiley +1 more sourceClinical features and incidence of central nervous system involvement in patients with adult T‐cell leukaemia/lymphoma
British Journal of Haematology, EarlyView.Summary
Central nervous system (CNS) involvement is a known complication of adult T‐cell leukaemia/lymphoma (ATL), but its clinical characteristics and incidence still remain unclear. This study characterized the clinical features and incidence of CNS involvement in patients with ATL (CNS‐ATL).Takuya Ueno, Makoto Yoshimitsu, Momone Sameshima, Taichi Nagano, Rika Akahoshi, Yusetsu Takeshita, Aya Shodai, Kodai Shima, Naosuke Arima, Yuhei Kamada, Daisuke Nakamura, Kenji Ishitsuka +11 morewiley +1 more sourceCombined Anti-CD20/Anti-CD38 Therapy in Posttransplant Focal Segmental Glomerulosclerosis Recurrence: A Retrospective, International, Multicenter Study. [PDF]
Transplant DirectCravedi P, Maggiore U, Mortari G, Alberici F, La Manna G, Goes N, Bouvier N, Comai G, Mehr AP, Gentile M, Palmisano A, Gessaroli E, Barbuto S, Caridi G, Bigatti C, Magnasco A, Bossini N, Kajana X, Spennacchio A, Gallon L, Ghiggeri GM, Vincenti F, Hullekes FE, Mehta RV, Riella LV, Verrina EE, Angeletti A. +26 moreeuropepmc +1 more sourceA comprehensive analysis of pirtobrutinib in Chinese patients with chronic lymphocytic leukaemia/small lymphocytic lymphoma (CLL/SLL): Results from the phase 3 study BRUIN CLL‐321
British Journal of Haematology, EarlyView.Summary
BRUIN CLL‐321 is the first prospective, randomized study conducted in covalent BTK inhibitor (cBTKi) pretreated chronic lymphocytic leukaemia/small lymphocytic lymphoma (CLL/SLL) patients. In this heavily pretreated population, pirtobrutinib significantly improved progression‐free survival (PFS) compared to investigator's choice (IC) of ...Shuhua Yi, Jiang Cao, Ru Feng, Keshu Zhou, Lihua Qiu, Fei Li, Hai Yan Yang, Hui Zhou, Wuhan Hui, Jie Cui, He Huang, Jiankun Zhu, Xiuhui Ye, Jeff Sharman, Lugui Qiu +14 morewiley +1 more sourcePredictors of rituximab efficacy in systemic sclerosis-associated interstitial lung disease: machine-learning analysis of the DESIRES trial. [PDF]
Rheumatology (Oxford)Kuzumi A, Oba K, Ebata S, Kashiwabara K, Ueda K, Uemura Y, Watadani T, Fukasawa T, Miura S, Yoshizaki-Ogawa A, Kage H, Sato S, Yoshizaki A. +12 moreeuropepmc +1 more sourceMolecular Monitoring after Autologous Stem Cell Transplantation and Preemptive Rituximab Treatment of Molecular Relapse; Results from the Nordic Mantle Cell Lymphoma Studies (MCL2 and MCL3) with Median Follow-Up of 8.5 Years
, 2016 Arne Kolstad, Lone Bredo Pedersen, Christian Winther Eskelund, Simon Husby, Kirsten Grønbæk, Mats Jerkeman, Anna Laurell, Riikka Räty, Erkki Elonen, Niels Smedegaard Andersen, Peter de Nully Brown, Eva Kimby, Hans Bentzen, Christer Sundström, Mats Ehinger, Marja‐Liisa Karjalainen‐Lindsberg, Jan Delabie, Elisabeth Ralfkiær, Unn‐Merete Fagerli, Herman Nilsson‐Ehle, Grete F. Lauritzsen, Outi Kuittinen, Carsten Utoft Niemann, Christian H. Geisler +23 moreopenalex +1 more sourceClinical features and comorbidity patterns in early and very early rheumatoid arthritis: Insights from a China nationwide survey
Rheumatology &Autoimmunity, EarlyView.Haojie Xu, Liyun Zhang, Yuehong Huo, Rui Wu, Lijun Wu, Ling Lei, Linyu Geng, Chunyu Tan, Xiaomei Li, Ru Li, Yin Su, the Women's Rheumatoid Arthritis Research Collaborative Group +11 morewiley +1 more source
